{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:54:55Z","timestamp":1792457695210,"version":"4.5.0"},"reference-count":151,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jaad.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaad.2019.08.049","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T03:30:26Z","timestamp":1572924626000},"page":"161-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":197,"title":["Joint American Academy of Dermatology\u2013National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients"],"prefix":"10.1016","volume":"82","author":[{"given":"Alan","family":"Menter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Cordoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Kroshinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boni E.","family":"Elewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth B.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Kiselica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Kivelevitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Korman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig L.","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Lichten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal N.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia L.","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun L.","family":"Pathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Farley Prater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena N.","family":"Rupani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Stoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Strober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily B.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jashin J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhya","family":"Hariharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Elmets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","article-title":"Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaad.2018.06.056","article-title":"Psoriasis: which therapy for which patient: focus on special populations and chronic infections","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib4","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jaad.2018.08.014","article-title":"Stigmatizing attitudes toward persons with psoriasis among laypersons and medical students","volume":"80","author":"Pearl","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/bjd.12437","article-title":"Clinical experience and psychometric properties of the Children\u2019s Dermatology Life Quality Index (CDLQI), 1995-2012","volume":"169","author":"Salek","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2133.2003.05157.x","article-title":"The Children's Dermatology Life Quality Index: validation of the cartoon version","volume":"148","author":"Holme","year":"2003","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.0905-6157.2003.00088.x","article-title":"Measurement of body surface area in atopic dermatitis using specific PC software (ScoradCard)","volume":"15","author":"Tripodi","year":"2004","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib8","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1365-2133.2010.09993.x","article-title":"A cross-sectional study using the Children\u2019s Dermatology Life\u00a0Quality Index (CDLQI) in childhood psoriasis: negative\u00a0effect on quality of life and moderate correlation of CDLQI with severity scores","volume":"163","author":"de Jager","year":"2010","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib9","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","article-title":"The Children\u2019s Dermatology Life Quality Index (CDLQI): initial validation and practical use","volume":"132","author":"Lewis-Jones","year":"1995","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1525-1470.2011.01408.x","article-title":"Environmental risk factors in pediatric psoriasis: a multicenter case-control study","volume":"28","author":"Ozden","year":"2011","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/jamadermatol.2013.1078","article-title":"Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study","volume":"149","author":"Paller","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jamadermatol.2014.324","article-title":"Excess adiposity preceding pediatric psoriasis","volume":"150","author":"Becker","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1525-1470.2000.01746.x","article-title":"A comparative study of pediatric onset psoriasis with adult onset psoriasis","volume":"17","author":"Raychaudhuri","year":"2000","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/mjd.2001.110876","volume":"44","author":"Naldi","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.1992.01680110049004","article-title":"The role of streptococcal infection in the initiation of guttate psoriasis","volume":"128","author":"Telfer","year":"1992","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1525-1470.2007.00424.x","article-title":"Plaque type psoriasiform eruption following Kawasaki disease","volume":"24","author":"Yoon","year":"2007","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2019.08.049_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5070\/D36221Q3W7","article-title":"Psoriasis in a 3-month-old infant with Kawasaki disease","volume":"15","author":"Liao","year":"2009","journal-title":"Dermatol Online J"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaad.2016.02.1146","article-title":"Psoriasiform eruptions during Kawasaki disease (KD): a distinct phenotype","volume":"75","author":"Haddock","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"11-12","key":"10.1016\/j.jaad.2019.08.049_bib19","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1365-2036.2011.04866.x","article-title":"Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature","volume":"34","author":"Cullen","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1525-1470.2011.01521.x","article-title":"Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children","volume":"29","author":"Perman","year":"2012","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/pde.13081","article-title":"Psoriasis and psoriasiform eruptions in pediatric patients with inflammatory bowel disease treated with anti-tumor necrosis factor alpha agents","volume":"34","author":"Eickstaedt","year":"2017","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00128071-200001030-00003","article-title":"Drug-induced psoriasis. Recognition and management","volume":"1","author":"Tsankov","year":"2000","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","volume":"80","author":"Elmets","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/bjd.13781","article-title":"Risk of psoriasis in patients with childhood asthma: a Danish nationwide cohort study","volume":"173","author":"Egeberg","year":"2015","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000381913","article-title":"Epidemiology and comorbidity in children with psoriasis and atopic eczema","volume":"231","author":"Augustin","year":"2015","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","article-title":"The epidemiology of psoriatic arthritis","volume":"41","author":"Ogdie","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"issue":"7","key":"10.1016\/j.jaad.2019.08.049_bib27","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jamadermatol.2017.0499","article-title":"Pediatric psoriasis comorbidity screening guidelines","volume":"153","author":"Osier","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/BOR.0b013e328348b278","article-title":"Psoriatic juvenile idiopathic arthritis: a tale of two subgroups","volume":"23","author":"Stoll","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1396-0296.2004.04039.x","article-title":"Pediatric psoriasis and psoriatic arthritis","volume":"17","author":"Lewkowicz","year":"2004","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2009.09593.x","article-title":"Epidemiology and comorbidity of psoriasis in children","volume":"162","author":"Augustin","year":"2010","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib31","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/bjd.12441","article-title":"Childhood-onset psoriasis: association with future cardiovascular and metabolic comorbidities","volume":"169","author":"Mahe","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/pde.13382","article-title":"Pediatric psoriasis: evolving perspectives","volume":"35","author":"Eichenfield","year":"2018","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib33","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/pde.12218","article-title":"Prevalence of the metabolic syndrome in children with psoriatic disease","volume":"30","author":"Goldminz","year":"2013","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1346-8138.2011.01281.x","article-title":"Relationship of the body mass index and childhood psoriasis in a Chinese Han population: a hospital-based study","volume":"39","author":"Zhu","year":"2012","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2133.2009.09276.x","article-title":"Overweight and childhood psoriasis","volume":"161","author":"Boccardi","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.049_bib36","doi-asserted-by":"crossref","unstructured":"Hagan JF, Shaw JS, Duncan PM, et\u00a0al. Bright Futures\/American Academy of Pediatrics. Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents. Recommendations for Preventive Pediatric Health Care. 4th ed. Elk Grove Village, IL: American Academy of Pediatritcs; 2017.","DOI":"10.1542\/9781610020237"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2340\/00015555-0931","article-title":"High body mass index in adolescent girls precedes psoriasis hospitalization","volume":"90","author":"Bryld","year":"2010","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"10.1016\/j.jaad.2019.08.049_bib38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/ped.13309","article-title":"Pediatric psoriasis: should we be concerned with comorbidity? Cross-sectional study","volume":"59","author":"Kelati","year":"2017","journal-title":"Pediatr Int"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jpeds.2011.03.006","article-title":"The association of psoriasis and elevated blood lipids in overweight and obese children","volume":"159","author":"Koebnick","year":"2011","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib40","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jaad.2017.08.034","article-title":"Cardiovascular comorbidities of pediatric psoriasis among hospitalized children in the United States","volume":"77","author":"Kwa","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The \u2018psoriatic march\u2019: a concept of how severe psoriasis may drive cardiovascular comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/09546630701364768","article-title":"Psoriasis comorbidities","volume":"19","author":"Gottlieb","year":"2008","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/JID.2015.385","article-title":"Characterization of lipoprotein composition and function in pediatric psoriasis reveals a more atherogenic profile","volume":"136","author":"Tom","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.jaad.2019.08.049_bib45","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00592-017-1000-3","article-title":"Psoriasis in children with type 1 diabetes: a new comorbidity to be considered?","volume":"54","author":"Di Costanzo","year":"2017","journal-title":"Acta Diabetol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1525-1470.2011.01489.x","article-title":"The burden of childhood psoriasis","volume":"28","author":"de Jager","year":"2011","journal-title":"Pediatr Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2019.08.049_bib47","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archderm.141.12.1537","article-title":"Prevalence and treatment of psoriasis in the United Kingdom: a population-based study","volume":"141","author":"Gelfand","year":"2005","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/bjd.15095","article-title":"Psychiatric comorbidities in children and adolescents with psoriasis: a population-based cohort study","volume":"177","author":"Todberg","year":"2017","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1525-1470.2010.01195.x","article-title":"Psychiatric symptoms and health-related quality of life in children and adolescents with psoriasis","volume":"27","author":"Bilgic","year":"2010","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib50","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2011.11.948","article-title":"Risks of developing psychiatric disorders in pediatric patients with psoriasis","volume":"67","author":"Kimball","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib52","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jaad.2009.06.048","article-title":"Efficacy and safety of treatments for childhood psoriasis: a systematic literature review","volume":"62","author":"de Jager","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2019.08.049_bib53","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1517\/14656566.9.11.2001","article-title":"Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses","volume":"9","author":"Frangos","year":"2008","journal-title":"Expert Opin Pharmacother"},{"issue":"6 Pt 2","key":"10.1016\/j.jaad.2019.08.049_bib54","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/0190-9622(91)70319-W","article-title":"Halobetasol propionate cream by day and halobetasol propionate ointment at night for the treatment of pediatric patients with chronic, localized plaque psoriasis and atopic dermatitis","volume":"25","author":"Herz","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1525-1470.2007.00341.x","article-title":"Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients","volume":"24","author":"Brune","year":"2007","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib56","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2133.2003.05426.x","article-title":"Topical tacrolimus for facial psoriasis","volume":"149","author":"Clayton","year":"2003","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib57","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaad.2005.05.036","article-title":"Topical tacrolimus in the treatment of inverse psoriasis in children","volume":"53","author":"Steele","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib58","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1468-3083.2004.01054.x","article-title":"Psoriasis of the glans penis in a child successfully treated with Elidel (pimecrolimus) cream","volume":"18","author":"Amichai","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5070\/D37C3542MX","article-title":"Pimecrolimus 1 percent cream in the treatment of psoriasis in a child","volume":"12","author":"Mansouri","year":"2006","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2019.08.049_bib60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12887-016-0607-9","article-title":"Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis","volume":"16","author":"Siegfried","year":"2016","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jaad.2019.08.049_bib61","unstructured":"Prograf (tacrolimus) [package insert]. Toyama, Japan: Astellas Pharma Tech Co. Ltd. 2019."},{"key":"10.1016\/j.jaad.2019.08.049_bib62","series-title":"ELIDEL\u00ae (pimecrolimus) cream, 1% for topical use initial","year":"2014"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2015.12.009","article-title":"Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis","volume":"81","author":"Lovato","year":"2016","journal-title":"J Dermatol Sci"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib64","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2133.1996.tb01501.x","article-title":"Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris","volume":"135","author":"Darley","year":"1996","journal-title":"Br J Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.jaad.2019.08.049_bib65","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0190-9622(97)70281-0","article-title":"Topical calcipotriol in childhood psoriasis","volume":"36","author":"Oranje","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib66","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/000155599750009988","article-title":"Topical calcipotriol in childhood psoriasis","volume":"79","author":"Patrizi","year":"1999","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib67","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1525-1470.1999.00084.x","article-title":"A pilot study to assess the safety and efficacy of topical calcipotriol treatment in childhood psoriasis","volume":"16","author":"Park","year":"1999","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib68","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/pde.12429","article-title":"Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years","volume":"32","author":"Eichenfield","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/bjd.12895","article-title":"Calcipotriol\/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort","volume":"171","author":"van Geel","year":"2014","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib70","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/09546639709160525","article-title":"Calcipotriol and psoriasis in children","volume":"8","author":"Fabrizi","year":"2009","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib71","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1525-1470.2000.00024-3.x","article-title":"Infantile psoriasis: successful treatment with topical calcipotriol","volume":"17","author":"Choi","year":"2000","journal-title":"Pediatr Dermatol"},{"issue":"7240","key":"10.1016\/j.jaad.2019.08.049_bib72","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/bmj.320.7240.963","article-title":"Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis","volume":"320","author":"Ashcroft","year":"2000","journal-title":"BMJ"},{"issue":"2 Pt 1","key":"10.1016\/j.jaad.2019.08.049_bib73","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0190-9622(96)90349-7","article-title":"A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis","volume":"35","author":"Lebwohl","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib74","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0190-9622(98)70323-8","article-title":"Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement","volume":"39","author":"Lebwohl","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib75","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1525-1470.2007.00421.x","article-title":"Childhood nail psoriasis: a useful treatment with tazarotene 0.05%","volume":"24","author":"Diluvio","year":"2007","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib76","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000278241","article-title":"Dithranol therapy in childhood psoriasis: unjustifiably on the verge of falling into oblivion","volume":"220","author":"de Jager","year":"2010","journal-title":"Dermatology"},{"issue":"11","key":"10.1016\/j.jaad.2019.08.049_bib77","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-4362.1994.tb01005.x","article-title":"Efficacy of short-contact therapy with dithranol in childhood psoriasis","volume":"33","author":"Zvulunov","year":"1994","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib78","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjd.12621","article-title":"The effectiveness and safety of short-contact dithranol therapy in paediatric psoriasis: a prospective comparison of regular day care and day care with telemedicine","volume":"170","author":"Oostveen","year":"2014","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib79","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1185\/03007998309111752","article-title":"An open assessment of 0.1% dithranol in a 17% urea base (\u2018Psoradrate\u2019 0.1%) in the treatment of psoriasis of children","volume":"8","author":"Guerrier","year":"1983","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1525-1470.1984.tb00434.x","article-title":"Resistant childhood psoriasis: an analysis of patients seen in a day-care center","volume":"2","author":"Menter","year":"1984","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib81","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1525-1470.2010.01124.x","article-title":"Results of Goeckerman treatment for psoriasis in children: a 21-year retrospective review","volume":"27","author":"Kortuem","year":"2010","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib82","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1525-1470.2008.00774.x","article-title":"Genotoxic hazard and cellular stress in pediatric patients treated for psoriasis with\u00a0the Goeckerman regimen","volume":"26","author":"Borska","year":"2009","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib83","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.mrgentox.2010.01.003","article-title":"Urinary mutagenicity and genotoxic risk in children with psoriasis after therapeutic exposure to polycyclic aromatic hydrocarbons and ultraviolet radiation","volume":"696","author":"Borska","year":"2010","journal-title":"Mutat Res"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib84","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1525-1470.2007.00548.x","article-title":"Immunologic changes in TNF-alpha, sE-selectin, sP-selectin, sICAM-1, and IL-8 in pediatric patients treated for psoriasis with the Goeckerman regimen","volume":"24","author":"Borska","year":"2007","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2019.08.049_bib85","doi-asserted-by":"crossref","first-page":"302528","DOI":"10.1155\/2014\/302528","article-title":"Oxidative damage to nucleic acids and benzo(a)pyrene-7,8-diol-9,10-epoxide-DNA adducts and chromosomal aberration in children with psoriasis repeatedly exposed to crude coal tar ointment and UV radiation","volume":"2014","author":"Borska","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jaad.2019.08.049_bib86","first-page":"229","article-title":"Treatment of psoriasis","volume":"24","author":"Goeckerman","year":"1925","journal-title":"Northwest Med"},{"issue":"6 Pt 1","key":"10.1016\/j.jaad.2019.08.049_bib87","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0190-9622(99)70076-9","article-title":"Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris","volume":"40","author":"Walters","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib88","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1525-1470.2008.00773.x","article-title":"Phototherapy in childhood","volume":"25","author":"Ersoy-Evans","year":"2008","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib89","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1468-3083.2010.03832.x","article-title":"Narrow band UVB: is it effective and safe for paediatric psoriasis and atopic dermatitis?","volume":"25","author":"Pavlovsky","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib90","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-4632.2007.03148.x","article-title":"Narrow-band UV-B phototherapy in childhood psoriasis","volume":"46","author":"Jain","year":"2007","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib91","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1525-1470.2008.00729.x","article-title":"Enhanced response of childhood psoriasis to narrow-band UV-B phototherapy with preirradiation use of mineral oil","volume":"25","author":"Jain","year":"2008","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib92","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/pde.13072","article-title":"Use of phototherapy in children","volume":"34","author":"Eustace","year":"2017","journal-title":"Pediatr Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2019.08.049_bib93","first-page":"881","article-title":"Systemic treatment of recalcitrant pediatric psoriasis: a case series and literature review","volume":"14","author":"Garber","year":"2015","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib94","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2230.2006.02061.x","article-title":"Narrowband ultraviolet B (UVB) phototherapy in children","volume":"31","author":"Jury","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib95","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2230.2008.02740.x","article-title":"Hair in psoriasis: a prospective, blinded scanning electron microscopic study","volume":"33","author":"Kumar","year":"2008","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib96","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1525-1470.2005.22216.x","article-title":"Comparison of the efficacy and safety of the 308 nm excimer laser for the treatment of localized psoriasis in adults and in children: a pilot study","volume":"22","author":"Pahlajani","year":"2005","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib97","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1525-1470.2003.03016.x","article-title":"Phototherapy in pediatric patients","volume":"20","author":"Pasic","year":"2003","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib98","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1525-1470.1996.tb00711.x","article-title":"Experience with UVB phototherapy in children","volume":"13","author":"Tay","year":"1996","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib99","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1111\/pde.12632","article-title":"Role of narrowband ultraviolet B phototherapy in the treatment of childhood psoriasis in Asian children","volume":"32","author":"Wong","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1468-3083.2009.03425.x","article-title":"Paediatric psoriasis\u2014narrowband UVB treatment","volume":"24","author":"Zamberk","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.jaad.2019.08.049_bib101","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jamadermatol.2017.3029","article-title":"Safety of systemic agents for the treatment of pediatric psoriasis","volume":"153","author":"Bronckers","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib102","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1525-1470.2008.00629.x","article-title":"Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India","volume":"25","author":"Kaur","year":"2008","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib103","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2230.2008.02907.x","article-title":"Methotrexate treatment in 13 children with severe plaque psoriasis","volume":"34","author":"Collin","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib104","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/09546634.2014.996515","article-title":"Methotrexate in pediatric plaque-type psoriasis: long-term daily clinical practice results from the Child-CAPTURE registry","volume":"26","author":"van Geel","year":"2015","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib105","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/1346-8138.13713","article-title":"Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: a multicenter, cohort study","volume":"44","author":"Ergun","year":"2017","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib106","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/jdv.12749","article-title":"Systemic treatments in paediatric psoriasis: a systematic evidence-based update","volume":"29","author":"van Geel","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib107","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1525-1470.1994.tb00602.x","article-title":"Methotrexate in childhood psoriasis","volume":"11","author":"Kumar","year":"1994","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib108","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/09546634.2015.1115813","article-title":"Clinical experience with systemic cyclosporine A treatment in severe childhood psoriasis","volume":"27","author":"Bulbul Baskan","year":"2016","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib109","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/09546634.2015.1034072","article-title":"Systemic cyclosporine treatment in severe childhood psoriasis: a retrospective chart review","volume":"28","author":"Dogra","year":"2017","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1525-1470.2001.018003246.x","article-title":"Low dose cyclosporin A treatment in generalized pustular psoriasis","volume":"18","author":"Kilic","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2019.08.049_bib111","unstructured":"Cyclosporine [package insert]. East Hanover, NJ: Novartis Pharmaceutical Corporation. 2015."},{"issue":"11","key":"10.1016\/j.jaad.2019.08.049_bib112","first-page":"1532","article-title":"Cyclosporine in childhood psoriasis","volume":"137","author":"Mahe","year":"2001","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib113","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2133.1996.tb03889.x","article-title":"Consensus conference on cyclosporin A microemulsion for psoriasis, June 1996","volume":"135","author":"Berth-Jones","year":"1996","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib114","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/09546630310012136","article-title":"Cyclosporin in childhood psoriasis","volume":"14","author":"Perrett","year":"2003","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1468-3083.2006.01562.x","article-title":"Cyclosporin A treatment in severe childhood psoriasis","volume":"20","author":"Pereira","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib116","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2133.2002.04836.x","article-title":"Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels","volume":"147","author":"Heydendael","year":"2002","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib117","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/09546634.2015.1120852","article-title":"Effectiveness and safety of cyclosporine in pediatric plaque psoriasis: a multicentric retrospective analysis","volume":"27","author":"Di Lernia","year":"2016","journal-title":"J Dermatolog Treat"},{"issue":"6 Pt 2","key":"10.1016\/j.jaad.2019.08.049_bib118","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0190-9622(90)70354-K","article-title":"Laboratory monitoring of cyclosporine levels: guidelines for the dermatologist","volume":"23","author":"Mockli","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib119","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1525-1470.2009.00918.x","article-title":"Generalized pustular psoriasis in a 6-week-old infant","volume":"26","author":"Chao","year":"2009","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib120","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/pde.12296","article-title":"Pustular psoriasis in childhood and adolescence: a 20-year single-center experience","volume":"31","author":"Popadic","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib121","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/09546634.2017.1395798","article-title":"Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review","volume":"29","author":"Chen","year":"2018","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib122","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1525-1470.1988.tb00902.x","article-title":"Etretinate in severe psoriasis of children","volume":"5","author":"Rosinska","year":"1988","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib123","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archderm.1987.01660260100023","article-title":"Etretinate therapy for generalized pustular psoriasis in children","volume":"123","author":"Shelnitz","year":"1987","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib124","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2133.2004.06181.x","article-title":"Successful use of acitretin in conjunction with narrowband ultraviolet B phototherapy in a child with severe pustular psoriasis, von Zumbusch type","volume":"151","author":"Kopp","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.049_bib125","unstructured":"Absorica (isotretinoin) [package insert]. Humaco, PR: Galephar Pharmaceuticals Research, Inc. 2018."},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib126","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0049-0172(95)80039-5","article-title":"Rheumatologic complications of vitamin A and retinoids","volume":"24","author":"Nesher","year":"1995","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib127","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2310\/7750.2006.00065","article-title":"Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature","volume":"10","author":"Halverstam","year":"2006","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2019.08.049_bib128","unstructured":"Soriatane (acitretin) capsules [package insert]. Research Triangle\u00a0Park, NC: Stiefel Laboratories, Inc. 2017."},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib129","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/pde.12351","article-title":"A systematic review of systemic medications for pustular psoriasis in pediatrics","volume":"31","author":"Posso-De Los Rios","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000363103","article-title":"Systemic treatment with fumaric acid esters in six paediatric patients with psoriasis in a psoriasis centre","volume":"229","author":"Steinz","year":"2014","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib131","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3109\/09546634.2015.1088131","article-title":"Fumaric acid esters in recalcitrant pediatric psoriasis: a prospective, daily clinical practice case series","volume":"27","author":"van Geel","year":"2016","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib132","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/bjd.12231","article-title":"Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from the Netherlands","volume":"168","author":"Balak","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib133","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.det.2012.12.005","article-title":"Systemic treatments for severe pediatric psoriasis: a practical approach","volume":"31","author":"Marqueling","year":"2013","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2019.08.049_bib134","series-title":"Lexicomp Pediatric & Neonatal Dosage Handbook","author":"Takemoto","year":"2019"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa066886","article-title":"Etanercept treatment for children and adolescents with plaque psoriasis","volume":"358","author":"Paller","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib136","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaad.2010.02.060","article-title":"Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial","volume":"64","author":"Langley","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib137","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaad.2010.04.004","article-title":"Long-term etanercept in pediatric patients with plaque psoriasis","volume":"63","author":"Paller","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib138","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2015.09.056","article-title":"Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis","volume":"74","author":"Paller","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"10089","key":"10.1016\/j.jaad.2019.08.049_bib139","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(17)31189-3","article-title":"Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial","volume":"390","author":"Papp","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib140","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaad.2015.07.002","article-title":"Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study","volume":"73","author":"Landells","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib141","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/pde.12782","article-title":"Treatment of moderate to severe pediatric psoriasis: a retrospective case series","volume":"33","author":"Klufas","year":"2016","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.049_bib142","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","volume":"80","author":"Menter","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib143","first-page":"1","article-title":"The evolving role of biologics in the\u00a0treatment of pediatric psoriasis","volume":"18","author":"Luu","year":"2013","journal-title":"Skin Therapy Lett"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.049_bib144","first-page":"323","article-title":"Efficacy and safety of etanercept in children and adolescents aged > or\u00a0= 8 years with severe plaque psoriasis","volume":"20","author":"Landells","year":"2010","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib145","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jaad.2009.10.046","article-title":"Intermittent etanercept therapy in pediatric patients with psoriasis","volume":"63","author":"Siegfried","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib146","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1525-1470.2006.00174.x","article-title":"Etanercept for psoriasis in the pediatric population: experience in nine patients","volume":"23","author":"Hawrot","year":"2006","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib147","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10067-013-2378-0","article-title":"Long-term safety of anti-TNF-alpha in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients","volume":"33","author":"Costa","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.049_bib148","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijmyco.2016.02.005","article-title":"The pros and cons of the QuantiFERON test for the diagnosis of tuberculosis, prediction of disease progression, and treatment monitoring","volume":"5","author":"Ndzi","year":"2016","journal-title":"Int J Mycobacteriol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.049_bib149","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1513\/AnnalsATS.201508-532OC","article-title":"Cumulative false-positive QuantiFERON-TB interferon-gamma release assay results","volume":"13","author":"Gamsky","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.40726","article-title":"Special article: 2018 American College of Rheumatology\/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis","volume":"71","author":"Singh","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.049_bib151","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaad.2008.01.006","article-title":"National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening","volume":"58","author":"Kimball","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.049_bib152","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3122\/jabfm.17.1.59","article-title":"Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature","volume":"17","author":"Ebell","year":"2004","journal-title":"J Am Board Fam Pract"},{"key":"10.1016\/j.jaad.2019.08.049_bib153","series-title":"Administrative Regulation\u2014Evidence-Based Clinical Practice Guidelines","year":"2014"}],"updated-by":[{"DOI":"10.1016\/j.jaad.2020.01.061","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000}}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219326556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219326556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T11:55:42Z","timestamp":1664798142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219326556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":151,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0190962219326556"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.08.049","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jaad.2020.01.061","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Joint American Academy of Dermatology\u2013National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.08.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}